Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NETWORK × Methylphenidate × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 2 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Radiotherapy 213 Cisplatin 178 Cyclophosphamide 166 Doxorubicin 134 Paclitaxel 124 Vincristine 122 Filgrastim 120 Etoposide 101 Carboplatin 98 Methotrexate 82 Gemcitabine 82 Docetaxel 78 Cytarabine 77 Gene Expression Profiling 74 Fluorouracil 74 Prednisone 71 Granulocyte Colony-Stimulating Factor 65 Dexamethasone 65 Leucovorin 61 Polymerase Chain Reaction 47 Immunohistochemistry 46 Microarray Analysis 40 Daunorubicin 38 Irinotecan 37 Ifosfamide 37 Temozolomide 35 Amplified Fragment Length Polymorphism Analysis 33 Peripheral Blood Stem Cell Transplantation 32 Cetuximab 32 Flow Cytometry 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003266 2023-06-18

Methylphenidate in Treating Patients With Melanoma

Eastern Cooperative Oncology Group

Phase 3 Completed

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡